Sumitomo Mitsui Trust Group, Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 405 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sumitomo Mitsui Trust Group, Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$221,200
-61.0%
1,400
-68.0%
0.00%
Q1 2024$567,164
-11.6%
4,381
-34.1%
0.00%
Q4 2023$641,452
-33.8%
6,652
-16.8%
0.00%
-100.0%
Q3 2023$968,790
+45.4%
7,992
+37.3%
0.00%0.0%
Q2 2023$666,506
-25.9%
5,820
-10.8%
0.00%0.0%
Q1 2023$898,927
-25.4%
6,522
-29.9%
0.00%0.0%
Q4 2022$1,205,742
+16.2%
9,305
-0.9%
0.00%0.0%
Q3 2022$1,038,000
+20.6%
9,386
-18.3%
0.00%0.0%
Q2 2022$861,000
-5.6%
11,482
-1.7%
0.00%0.0%
Q1 2022$912,000
-17.2%
11,678
-4.5%
0.00%0.0%
Q4 2021$1,101,000
-6.3%
12,226
-3.7%
0.00%0.0%
Q3 2021$1,175,000
-52.8%
12,702
-60.3%
0.00%0.0%
Q2 2021$2,489,000
-92.5%
32,016
-92.8%
0.00%
-95.2%
Q1 2021$33,326,000
-41.2%
447,155
+34.5%
0.02%
-43.2%
Q4 2020$56,690,000
+20.3%
332,513
-0.9%
0.04%
+15.6%
Q3 2020$47,134,000
-23.4%
335,639
-12.5%
0.03%
-25.6%
Q2 2020$61,505,000
+53.2%
383,591
-6.6%
0.04%
+22.9%
Q1 2020$40,154,000
-23.0%
410,484
+1.5%
0.04%
-14.6%
Q4 2019$52,163,000
+70.9%
404,238
-0.3%
0.04%
+51.9%
Q3 2019$30,530,000
+129.7%
405,332
+363.3%
0.03%
+125.0%
Q2 2019$13,294,000
+162.6%
87,492
+106.0%
0.01%
+140.0%
Q1 2019$5,062,00042,4680.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 1,369,909$84,126,00014.76%
Perceptive Advisors 3,395,236$208,506,00013.46%
Ghost Tree Capital, LLC 400,000$24,564,0003.98%
Granite Point Capital Management, L.P. 160,000$9,826,0003.84%
Sio Capital Management, LLC 86,500$5,312,0003.66%
Ghost Tree Capital, LLC 350,000$21,494,0003.49%
Redmile Group, LLC 640,400$39,327,0003.13%
DIALECTIC CAPITAL MANAGEMENT, LP 78,408$4,815,0003.00%
SPHERA FUNDS MANAGEMENT LTD. 263,047$16,154,0002.63%
FT Options LLC 49,025$3,011,0002.39%
View complete list of SAREPTA THERAPEUTICS INC shareholders